Alternatives to Slate Medicines
Slate Medicines is a Biotechnology tool: advancing anti-PACAP therapies for the prevention of migraine and other headache disorders. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Slate Medicines
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
CRISPR Therapeutics64BiotechnologyZug, Switzerland$547.0MBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website
mbiomics48BiotechnologyMunich, Germany$12.0MAdvancing scalable microbiome-based therapeutics for severe and chronic diseases.
- Website
ImmunityBio44BiotechnologyCulver City, USA$75.0MA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
- Website FOForlong Biotechnology42BiotechnologyShanghai, China$22.5M
Clinical-stage biotech company developing transformative cytokine therapies.
- Website ACAcurex Biosciences34BiotechnologySan Carlos, USA$1.0M
Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders.
- JUJuno Therapeutics66BiotechnologySeattle, United States$316.7M
Biotechnology company focused on developing cancer immunotherapies.
- Website
Kite Pharma66BiotechnologySanta Monica, United States$421.2MBiotechnology company developing and commercializing cell therapies for cancer treatment.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Seaport Therapeutics62BiotechnologyCambridge, USA$340.0MDeveloping novel therapeutics to restore gut lymphatic function.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Supernus Pharmaceuticals60BiotechnologyRockville, United States$17.5MBiopharmaceutical company developing and commercializing CNS disease treatments.
- CRCreate Medicines60BiotechnologyCambridge, USA$122.0M
Developing in vivo immunotherapies for autoimmune diseases and cancer.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Alcolase85BiotechnologyCopenhagen, DenmarkEnzyme-based technology to break down alcohol in the stomach.
Showing the 20 closest matches. See the rest on the Slate Medicines profile.
Compare Slate Medicines head to head
Side by side on what each one does, what it costs, and what real users report.